AC   CVCL_1Q86
DR   BioSample; SAMN03151990
DR   Wikidata; Q54899003
RX   PubMed=12907203;
RX   PubMed=16978912;
RX   PubMed=21868764;
CC   Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00407.
CC   Characteristics: Anoikis-resistant (PubMed=12907203).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12,13
ST   D13S317: 8,11,12
ST   D16S539: 8,9,12,13
ST   D5S818: 10,12,13
ST   D7S820: 9,10,12
ST   TH01: 6,8
ST   TPOX: 8,10,11
ST   vWA: 15,16,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 13
RX   PubMed=12907203; DOI=10.1016/S1368-8375(03)00049-6;
RA   Swan E.A., Jasser S.A., Holsinger F.C., Doan D., Bucana C.D.,
RA   Myers J.N.;
RT   "Acquisition of anoikis resistance is a critical step in the
RT   progression of oral tongue cancer.";
RL   Oral Oncol. 39:648-655(2003).
RX   PubMed=16978912; DOI=10.1016/j.oraloncology.2006.04.016;
RA   Kupferman M.E., Patel V., Sriuranpong V., Amornphimoltham P.,
RA   Jasser S.A., Mandal M., Zhou G., Wang J., Coombes K., Multani A.,
RA   Pathak S., Gutkind J.S., Myers J.N.;
RT   "Molecular analysis of anoikis resistance in oral cavity squamous cell
RT   carcinoma.";
RL   Oral Oncol. 43:440-454(2007).
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).